Akadeum Life Sciences, Inc.

Biotechnology ResearchUnited States11-50 Employees

The first new GMP cell separation modality in 40 years, Akadeum’s microbubble technology represents one of the first meaningful innovations in a critical early step of the cell therapy manufacturing process. Our kits can be easily incorporated into workflows, delivering consistently high performance while enabling up to a 42% reduction in the footprint of your current workflow and compatibility with both centralized and decentralized manufacturing models.

Akadeum is currently working with some of the largest corporations and forward-thinking leaders in the industry. The power of the Akadeum microbubble platform is an elegant and easy-to-use technology that can enable faster, more accurate, and scalable workflows to improve human health.

Healthier Cells. Better Therapies.

Sign up for free to view info

Email Format Employee directory